AI in Genomics Market

Global AI in Genomics Market Size, Share & Trends Analysis Report, By Delivery Mode (On-Premise and Cloud-Based), By Functionality (Genome Sequencing and Gene Editing), By Application (Translational Precision Medicine, Clinical and Genomic Diagnosis, and Others), By End-User (Pharmaceutical and Biotechnology Companies, Research Centers, Academic Institutes and Government Organizations, and Others), Forecast 2022-2028

Published: Jun 2022 | Report Code: OMR2026758 | Category : Advanced Technologies | Delivery Format: /

The global AI in genomics market is expected to grow at a significant CAGR of 50.2% during the forecast period.  The growth of the market is primarily driven by the rising investment made by the government in the field of genomics, coupled with the application of genomics in areas such as oncology, pharmacology, infectious diseases, and genetic medicine. Moreover, in evaluating tailored treatment plans, and clinical care, genomics medicine uses machine learning and artificial intelligence as it includes the study of gene mutations. The utilization of artificial intelligence in genomics applications such as precision medicine, diagnostics, drug discovery and development, and others offers lucrative growth opportunities in the coming years.

New product developments and launches by market players are further supporting the market growth.  For instance, in March 2021, Empiric Logic along with the University College Dublin (UCD), announced that it has secured nearly $89,600 in grant funding under Enterprise Ireland’s innovation partnership program. With this funding, the company develops a novel genomics data protection methodology.  Empiric Logic has developed an artificial intelligence (AI), data analysis, and bioinformatics orchestration platform to simplify the exploration of human health, using genomics and other data.  

Segmental Outlook 

The global AI in genomics market is segmented based on delivery mode, functionality, application, and end-user. Based on the delivery mode, the market is segmented into on-premise, and cloud-based. Based on functionality, the market is segmented into genome sequencing and gene editing. Based on application, the market is segmented into translational precision medicine, clinical and genomic diagnosis, and others. Clinical and genomic diagnosis is expected to hold a promising share in the market. Continuous innovation in clinical genomics, along with the availability of several technologies for disease detection provides different options for detecting genetic disorders such as RT-PCR, microarray sequencing, and next-generation sequencing. Thus, the steady innovation, and accessible options for detecting disease, resulted in the growth of the clinical and genomic diagnosis segment.

Cloud-Based AI in Genomics is Expected to Hold Significant Share During the Forecast Period 

Cloud-based AI in genomics is expected to witness significant growth during the forecast period. The major factor responsible for the growth of the segment is the ability of cloud-based solutions that offers access, analyze, and store data and compile all of it in a single location. Moreover, the flexible price and on-demand nature of cloud computing allow the researchers to tackle complex genomics projects, and allows to manage large-scale data that has outpaced the capacity of on-premises infrastructure. Owing to its various advantages, there is a significant demand for cloud-based solutions during the forecast period. 

Regional Outlook

The global AI in genomics market is further segmented based on geography including North America (The US and Canada), Europe (Italy, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (Middle East & Africa and Latin America). Asia-Pacific is expected to witness significant growth in the market during the forecast period. The growth is mainly witnessed owing to the rising adoption of artificial intelligence (AI) in pharmaceuticals, along with rising private and public investment in the field of genomics. This is expected to drive the market growth in the Asia-Pacific region. 

Global AI in Genomics Market Growth by Region, 2021-2028

Global AI in Genomics Market Growth by Region

North American Region Holds Potential Share in the Market

North American region is expected to hold a potential share in the market. This is mainly attributed owing to the rising government initiatives and investment by market players to promote precision medicine practices in the North American region.  Moreover, the key players are rapidly adopting partnerships, mergers and acquisitions, and collaborations, to stay competitive in the market. For instance, in May 2022, Illumina Inc. and Deerfield Management entered into a five-year R&D partnership. Under the terms of the agreement, the company utilizes Illumina’s genetically driven AI discovery platform and genomic tool, while Deerfield provides expertise to guide potential candidates for drug discovery, and drive a step-change in the pace and efficiency of therapeutic development. 

Market Players Outlook

The major companies operating in the global AI in genomics market include IBM Corp., Microsoft Corp., Google LLC, and NVIDIA Corp., among others. The market players are contributing significantly to the market growth by the adoption of various strategies including partnerships, mergers and acquisitions, collaborations, and new product launches, to stay competitive in the market. For instance, in October 2021, C2i Genomics announced its technology co-development and expansion into China through a strategic partnership with NuProbe Global. The C2i Genomics advanced cloud platform and state-of-art algorithm provide synergy to NuProbe’s ultra-sensitive sequencing technology. Moreover, as a part of the deal, the company provides genome signal integration and ultra-sensitive interception of cancer hotspots, and MSI, which significantly improve cancer screening. 

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global AI in genomics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future. 
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

Current Industry Analysis and Growth Potential Outlook

Recovery Scenario Of Global AI in Genomics Market 

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segment

1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight and Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis

3.1.1. IBM Corp.

3.1.1.1. Overview

3.1.1.2. Financial Analysis 

3.1.1.3. SWOT Analysis

3.1.1.4. Recent Developments

3.1.2. Microsoft Corp.

3.1.2.1. Overview

3.1.2.2. Financial Analysis 

3.1.2.3. SWOT Analysis

3.1.2.4. Recent Developments

3.1.3. Google LLC

3.1.3.1. Overview

3.1.3.2. Financial Analysis 

3.1.3.3. SWOT Analysis

3.1.3.4. Recent Developments

3.1.4. NVIDIA Corp.

3.1.4.1. Overview

3.1.4.2. Financial Analysis 

3.1.4.3. SWOT Analysis

3.1.4.4. Recent Developments

3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global AI in Genomics Market by Delivery Mode

4.1.1. On-Premise 

4.1.2. Cloud-Based 

4.2. Global AI in Genomics Market by Functionality 

4.2.1. Genome Sequencing 

4.2.2. Gene Editing

4.3. Global AI in Genomics Market by Application 

4.3.1. Translational Precision Medicine 

4.3.2. Clinical and Genomic Diagnosis 

4.3.3. Others

4.4. Global AI in Genomics Market by End-User

4.4.1. Pharmaceutical and Biotechnology Companies

4.4.2. Research Centers, Academic Institutes, and Government Organizations

4.4.3. Healthcare Providers

5.    Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain 

5.2.5. France

5.2.6. Rest of Europe 

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. South Korea

5.3.5. Rest of Asia-Pacific 

5.4. Rest of the World

6. Company Profiles

6.1. BenevolentAI

6.2. Data4Cure, Inc.

6.3. Deep Genomics

6.4. Diploid Inc.

6.5. DNAnexus, Inc.

6.6. Empiric Logic

6.7. Engine Biosciences Pte. Ltd. 

6.8. Fabric Genomics Inc. 

6.9. FDNA

6.10. Freenome Holdings Inc. 

6.11. GNX Data Systems Inc.Genoox

6.12. Lifebit Biotech Ltd. 

6.13. Seragon Pharmaceuticals

6.14. Sophia Genetics

6.15. Verge Genomics

1. GLOBAL AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERY MODE, 2021-2028 ($ MILLION)

2. GLOBAL ON PREMISE  AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL CLOUD-BASED AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

4. GLOBAL AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY FUNCTIONALITY, 2021-2028 ($ MILLION)

5. GLOBAL AI IN GENOME SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

6. GLOBAL AI IN GENE EDITING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

7. GLOBAL AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

8. GLOBAL AI IN GENOMICS FOR TRANSLATIONAL PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

9. GLOBAL AI IN GENOMICS FOR CLINICAL AND GENOMIC DIAGNOSIS  MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

10. GLOBAL AI IN GENOMICS FOR OTHERS APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

11. GLOBAL AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

12. GLOBAL AI IN GENOMICS FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

13. GLOBAL AI IN GENOMICS FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS  MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

14. GLOBAL AI IN GENOMICS FOR HEALTHCARE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

15. GLOBAL AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

16. NORTH AMERICAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

17. NORTH AMERICAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERY MODE, 2021-2028 ($ MILLION)

18. NORTH AMERICAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY FUNCTIONALITY, 2021-2028 ($ MILLION)

19. NORTH AMERICAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

20. NORTH AMERICAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

21. EUROPEAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

22. EUROPEAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERY MODE, 2021-2028 ($ MILLION)

23. EUROPEAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY FUNCTIONALITY, 2021-2028 ($ MILLION)

24. EUROPEAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

25. EUROPEAN AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

26. ASIA-PACIFIC AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

27. ASIA-PACIFIC AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERY MODE, 2021-2028 ($ MILLION)

28. ASIA-PACIFIC AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY FUNCTIONALITY, 2021-2028 ($ MILLION)

29. ASIA-PACIFIC AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

30. ASIA-PACIFIC AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

31. REST OF THE WORLD AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

32. REST OF THE WORLD AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERY MODE , 2021-2028 ($ MILLION)

33. REST OF THE WORLD AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY FUNCTIONALITY , 2021-2028 ($ MILLION)

34. REST OF THE WORLD AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2021-2028 ($ MILLION)

35. REST OF THE WORLD AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER , 2021-2028 ($ MILLION)

1. GLOBAL AI IN GENOMICS MARKET SHARE BY DELIVERY MODE, 2021-2028(%)

2. GLOBAL ON-PREMISE  AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL CLOUD-BASED AI IN GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

4. GLOBAL AI IN GENOMICS MARKET SHARE BY FUNCTIONALITY, 2021-2028(%)

5. GLOBAL AI IN GENOME SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

6. GLOBAL AI IN GENE EDITING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

7. GLOBAL AI IN GENOMICS MARKET SHARE BY APPLICATION, 2021-2028(%)

8. GLOBAL AI IN GENOMICS FOR TRANSLATIONAL PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

9. GLOBAL AI IN GENOMICS FOR CLINICAL AND GENOMIC DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

10. GLOBAL AI IN GENOMICS FOR OTHERS APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

11. GLOBAL AI IN GENOMICS MARKET SHARE BY END-USER, 2021-2028(%)

12. GLOBAL AI IN GENOMICS FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

13. GLOBAL AI IN GENOMICS FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

14. GLOBAL AI IN GENOMICS FOR HEALTHCARE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

15. GLOBAL AI IN GENOMICS MARKET SHARE BY REGION, 2021 VS 2028 (%)

16. US AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

17. CANADA AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

18. UK AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

19. GERMANY AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

20. SPAIN AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

21. FRANCE AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

22. ITALY AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

23. REST OF EUROPE AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

24. INDIA AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

25. CHINA AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

26. JAPAN AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

27. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)

28. REST OF THE WORLD AI IN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)